Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02397278 · ClinicalTrials.gov registry record · NA

Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee

A NA study, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT02397278: Completed NA study, sponsored by University of Colorado, Denver.

NCT02397278 is a NA study that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02397278, a NA study, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

This study plans to learn more about ways to treat a joint problem in the knee called Juvenile Osteochondritis Dissecans (OCD). The goal of this study is to see if injecting platelet-rich plasma (PRP) into the knee can help knee cartilage heal faster, and will try to determine whether the injections lead to improvements in pain, performance of activities of daily living, improvements is sports activities and overall function and symptoms reduction. The investigators will compare PRP treatment to conservative therapy.

Primary Outcome

Measured by dGEMRIC MRI

Interventions

  • DRUG Platelet rich plasma (PRP)

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2015-03
Est. Completion 2020-01-08
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT02397278 record still lists

NCT02397278 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Platelet rich plasma (PRP) is the first listed.

NCT02397278 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02397278 about?

NCT02397278 is a clinical study titled "Intra Articular Injections With Platelet Rich Plasma in Patients With Juvenile Osteochondritis Dissecans of the Knee". This study plans to learn more about ways to treat a joint problem in the knee called Juvenile Osteochondritis Dissecans (OCD). The goal of this study is to see if injecting platelet-rich plasma (PRP) into the knee can help knee cartilage heal faster, and will try to determine whether the injections...

What is the current status of trial NCT02397278?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2015-03. Estimated completion is 2020-01-08.

What interventions are being tested in trial NCT02397278?

The interventions under investigation include: Platelet rich plasma (PRP) (DRUG).

Who is sponsoring clinical trial NCT02397278?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02397278's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02397278, the US trial registry maintained by the National Library of Medicine. NCT02397278 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.